The Global Interdependence Center, in partnership with the Solve Long Covid Initiative, is continuing our conference series exploring the pandemic’s long-term healthcare, policy, and economic impact, specifically the implications of long haul COVID or long COVID. Together, we invite you to join us for the signature event of this series, an in-person conference in New York City on Thursday, May 19, 2022.

The purpose of our conference is to raise awareness of Long Covid by examining the science and research behind it and we hope can join us through one of our registration options, including in-person or virtual attendance. For those joining us in person, we are delighted to provide a Patient Rest Area on site at the event. This quiet space will be a rest area for patients who need to step away for flare-up/sensory overload equipped with cots/chairs/blankets.

Click here for a video recap of the conference, including speakers’ commentary on the importance of Long Covid research.

Continuing Education: Please email [email protected] for more information on how attendees of this event can receive continuing education credit from the CFP Board for 3 CE credit hours.

Agenda

8:00 a.m. | Registration and Continental Breakfast

9:00 a.m. | Welcome Remarks

• Oved Amitay, Chief Executive Officer at Solve M.E.
• Bill Kennedy, GIC Chair and Co-Founder, CEO and CIO of RiskBridge Advisors

9:15 a.m. | Session I: Scientific Research

• Bruce Patterson, MD, CEO and founder of IncellDx Inc.
• Marjan Islam, MD, Assistant Professor of Medicine in the Division of Pulmonary Medicine at Albert Einstein College of Medicine and Montefiore Medical Center
• Moderator: Kate Mudie, Research Senior Manager, Solve M.E.

10:30 a.m. | Session II: Industry-Specific Implications

• Clinical care and NIH’s RECOVER Study
  • Leora Horwitz, M.D., MHS, Director of the Center for Healthcare Innovation and Delivery Science, New York University – Langone Health
• Health Insurance
  • Nalini Raju, M.D. Senior Medical Director of CIGNA
• Pharmaceuticals
  • Thomas Equels, M.S., J.D., Chief Executive Officer of Aim Immunotech – Amplegin/Clinical Trials for Long Covid
  • Rich Moscicki, Chief Medical Officer of PhRMA
• Legal Outlook
  • Barbara B. Comerford, Founder of the Law Offices of Barbara B. Comerford
• Moderator: Oved Amitay, Chief Executive Officer at Solve M.E.

11:45 a.m. – 12:00 p.m. | Break

12:00 p.m. | Solve Long Covid Initiative Publication Material Announcement and Special Report

• Oved Amitay, Chief Executive Officer at Solve M.E.
• Melissa Smallwood, Co-Author: Long Covid Impact on Adult Americans: Early Indicators Estimating Prevalence and Cost

12:15 p.m. | Keynote: Vaccinating vs. Long Covid

• Dr. Peter Hotez and Dr. Maria Elena Bottazzi, Deans of the National School of Tropical Medicine at Baylor College of Medicine and Co-Directors of the Center for Vaccine Development at Texas Children’s Hospital
  Dr. Peter Hotez and Dr. Maria Elena Bottazzi are nominees for the 2022 Nobel Peace Prize for their work to develop and distribute a low-cost COVID-19 vaccine to people of the world without patent limitation. 
• Q&A with David Kotok, GIC Board Member and Chief Investment Officer of Cumberland Advisors

1:00 – 2:15 p.m. | Lunch

2:15 p.m. | Session III:  Economic Impact and Labor Market Challenges

• Philippa Dunne, Co-Editor, The Liscio Report and Sightlines Bulletin
• Holly Wade, GIC Board Member and Executive Director, National Federation of Independent Business (NFIB) Research Center
• Dana Peterson, GIC Board Member and Chief Economist & Center Leader of Economy, Strategy & Finance at The Conference Board
• Moderator: Kathleen Stephansen, GIC Chair Emeritus

3:30 p.m. | Session IV:  The Human Experience

• Elle Seibert, Registry Data Manager, Solve M.E. & Long COVID patient
• Susan Levine, MD, ME/CFS and Long COVID specialist, former chair of the CFS Federal Advisory Committee
• Lauren Nichols, Vice President, Body Politic
• Moderator: Emily Taylor, Vice President of Advocacy and Community Relations, Solve Long Covid Initiative/Solve M.E. and Co-Author: Long Covid Impact on Adult Americans: Early Indicators Estimating Prevalence and Cost

4:30 p.m. | Concluding Remarks

• Bill Kennedy, GIC Chair and Co-Founder, CEO and CIO of RiskBridge Advisors

COVID-19 Protocols

Masks are mandatory. Registrants must be fully vaccinated and show proof of vaccination upon arrival. Please do not attend if you have any COVID or flu like symptoms.

The New York Athletic Club Dress Code

• Gentlemen – Jackets are optional in most areas. Slacks, a collared shirt and dress shoes are permitted. Shirts must be tucked in. Jackets are required in the Main Dining Room and Cocktail Lounge.
• Ladies – Permitted attire refers to business suits, tailored pant or skirt ensembles, and dresses. Spandex, open midriffs, halter tops, leggings, denim and extremely short hemlines (more than 3″ above the knee, as a guideline) are not permitted.
• Jeans, T-shirts, sneakers and flip-flops are prohibited. Attire with rips, frays or tears or that displays language, motifs or insignias that may be deemed offensive are not permitted. 

About the David R. Kotok Global Healthcare Series

GIC launched the David R. Kotok Global Healthcare Series in 2020; a virtual program series focused on the roles health and healthcare policy play in the interdependent global community.  As a part of the series, the GIC has launched the “Analyzing Pandemics: Economic and Policy Impacts” executive briefings to explore the 100-year global pandemic event. Past briefings focused on the disease and the cure, COVID-19’s impact on food supply chains, artificial intelligence, climate change, and higher education.

In 2021, David Kotok and the Solve Long COVID Initiative offered a new gift to the GIC for funding, sponsorship, and logistical support for the Long COVID Program Series. The series serves as a neutral forum to elevate, vet, and share information about changing interdependencies caused by Long COVID’s impact on medical research, health care policy, fiscal policy, monetary policy, finance, trade, politics, and culture.

About the Solve Long Covid Initiative  

The Solve Long Covid Initiative represents a collection of new and expanded programs in research, advocacy, and education that will improve outcomes for the millions suffering from post-infection diseases. Based on more than 30 years of research and advocacy experience advancing the understanding of post-infection diseases, the Solve Long Covid Initiative takes a strategic approach to integrating pre-pandemic and post-pandemic knowledge and community insights. Our work in the post-infection disease space has allowed us to create connections and build partnerships with researchers, clinicians, patients, government, and industry leaders.